Amneal Pharmaceuticals has made public plans to close its factory in Hauppauge, New York in October-December of 2020, eliminating 220 jobs. The manufacturer of generic prescription drugs, which is headquartered in New Jersey, will transfer production from Hauppauge to a larger factory in South Yaphank and to other facilities around the globe. According to regulatory filings, the job cuts are part of a restructuring plan initiated due to increased competition, declining sales and lower drug prices. In addition to the jobs being lost in New York, the company plans to eliminate 330 other positions at sites in the U.S., Europe and India. Learn More